Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan
Stefano Omboni, Massimo Volpe
Cardiovascular Therapeutics (2018) Vol. 36, Iss. 6
Open Access | Times Cited: 19

Showing 19 citing articles:

Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety
Abdullah Shaito, Duong Thi Bich Thuan, Hoa Thi Phu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 323
Ginsenoside Rb1 in cardiovascular and cerebrovascular diseases: A review of therapeutic potentials and molecular mechanisms
Y Song, Chen Chen, Wei Li
Chinese Herbal Medicines (2024) Vol. 16, Iss. 4, pp. 489-504
Open Access | Times Cited: 6
Role of Herbal Active Compound in Cardiac Failure Treatment
Jyotsna Upadhyay, Amle Vandana Sonaji, Khonde Shital Trimbak, et al.
Journal for Research in Applied Sciences and Biotechnology (2024) Vol. 3, Iss. 2, pp. 83-102
Open Access | Times Cited: 4
Revolutionizing Hypertension Management: Cutting-Edge Microneedle Patch Infused with Zinc Oxide Nanoparticles for Advanced Transdermal Drug Delivery
Rubab Ijaz, Zulcaif Ahmad, Muhammad Imran Khan, et al.
BioNanoScience (2024) Vol. 14, Iss. 2, pp. 1397-1409
Closed Access | Times Cited: 4
Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial
Ali Samaha, Mirna Fawaz, Ali Salami, et al.
Biomolecules (2019) Vol. 9, Iss. 7, pp. 292-292
Open Access | Times Cited: 28
Qingda granule inhibits angiotensin Ⅱ induced VSMCs proliferation through MAPK and PI3K/AKT pathways
Na Yu, Aling Shen, Jianfeng Chu, et al.
Journal of Ethnopharmacology (2020) Vol. 258, pp. 112767-112767
Closed Access | Times Cited: 21
Exploring the Effectiveness and Safety of Azilsartan-Medoxomil/Chlorthalidone Versus Olmesartan-Medoxomil/Hydrochlorothiazide in Hypertensive Patients: A Meta-Analysis
Lakshya Kumar, Sundal Khuwaja, Aanand Kumar, et al.
Cureus (2023)
Open Access | Times Cited: 8
From Hypertension to Beyond: Unraveling the Diverse Mechanisms of Olmesartan in Disease Modulation
Laiba Rind, Tarique Mahmood, Mohammed Haris Siddiqui, et al.
Drug Research (2024) Vol. 74, Iss. 03, pp. 93-101
Open Access | Times Cited: 2
Olmesartan induced enteropathy affecting the entire gastrointestinal tract: a case report
N Van Horebeek, Romaric Croes, An Vonck, et al.
Acta Gastro Enterologica Belgica (2023) Vol. 86, Iss. 1, pp. 95-97
Open Access | Times Cited: 5
Determination of candesartan or olmesartan in hypertensive patient plasma using UPLC-MS/MS
Hyeon Cheol Jeong, Yo-Han Seo, Namyi Gu, et al.
Translational and Clinical Pharmacology (2021) Vol. 29, Iss. 4, pp. 226-226
Open Access | Times Cited: 9
The protective effects of Olmesartan against interleukin-29 (IL-29)-induced type 2 collagen degradation in human chondrocytes
Yunlong Liu, Junyi Liu, Yan Ma, et al.
Bioengineered (2022) Vol. 13, Iss. 1, pp. 1802-1813
Open Access | Times Cited: 6
Olmesartan Improves Hepatic Sinusoidal Remodeling in Mice with Carbon Tetrachloride-Induced Liver Fibrosis
Ying Wu, Xue Ge, Si-Ning Wang, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 3

Laiba Rind, Tarique Mahmood, Mohammed Wasim Siddiqui, et al.
Drug Research (2024) Vol. 74, Iss. 03
Open Access
Pengaruh Pemberian Jus Semangka Merah dan Kuning Terhadap Tekanan Darah Lansia Menderita Hipertensi

Jurnal Endurance (2022) Vol. 4, Iss. 2, pp. 411-418
Open Access | Times Cited: 2
ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients
Vivianne Presta, Ilaria Figliuzzi, Barbara Citoni, et al.
High Blood Pressure & Cardiovascular Prevention (2021) Vol. 28, Iss. 3, pp. 255-262
Open Access | Times Cited: 1
Experience of using telmisartan, atorvastatin and ursodeoxycholic acid in patients with arterial hypertension in combination with non-alcoholic fatty liver disease
О. А. Ефремова, Pavel Chernobay, Elena P. Pogurelskaya
Сибирский научный медицинский журнал (2021) Vol. 41, Iss. 5, pp. 75-82
Open Access | Times Cited: 1
Activity of Lysosomal Enzymes During Triple Combination Antihypertensive Treatment of Arterial Hypertension
Azayeva Nurana Rafail Gizi
European Journal of Clinical and Biomedical Sciences (2023)
Open Access
Comparison of safety and efficacy of combinations of Azilsartan-medoxomil/Chlorthalidone and Olmesartan-medoxomil /Hydrochlorothiazide among hypertensive patients: A meta-analysis and systematic review
Mahima Khatri, Satesh Kumar, Asad Ali Siddiqui, et al.
Authorea (Authorea) (2022)
Open Access
Comparison of safety and efficacy of combinations of Azilsartan-medoxomil/Chlorthalidone and Olmesartan-medoxomil /Hydrochlorothiazide among hypertensive patients: A meta-analysis and systematic review
Satesh Kumar, Kamran Mahfooz, Asad Ali Siddiqui, et al.
Authorea (Authorea) (2022)
Open Access
Page 1

Scroll to top